Rosacea in Patients with Skin of Color: Not Common, But Certainly Not Rare
rosaceaRosacea is defined by facial erythema and telangiectasias, two features that are more difficult to appreciate in patients with skin of color. To refine our ability to diagnose rosacea in all skin types, on day two of the 2021 Skin of Color Update virtual conference, we had an informative, evidence-based lecture, “Recognizing, Diagnosing, and Treating Rosacea in Patients with Skin of Color,” by …
rosacea
Oral Glycopyrrolate for Hyperhidrosis | Therapeutic Cheat Sheet
Glycopyrrolate for hyperhidrosisHyperhidrosis affects up to 4.8% of people in the United States, causing significant impacts in patient quality of life.1 Often times, the etiology of symptoms cannot be identified, resulting in a subset of disease termed “primary hyperhidrosis.” Symptoms may be focal or generalized. Because there is a scarcity of FDA-approved treatments for primary hyperhidrosis, treatment often requires a mu …
Glycopyrrolate for hyperhidrosis
Cosmeceutical Recommendations for Diverse Skin Types
cosmeceuticalsAt the 2021 Skin of Color Update, Dr. Heather Woolery-Lloyd, Director of the Skin of Color Division at the University of Miami Department of Dermatology,  delivered an excellent talk on cosmeceutical recommendations for patients with diverse skin types, a personal favorite subject of hers. Catch the pearls of her talk here! Hot Topics  in Cosmeceuticals Topical Cannabinoids – The skin has it …
cosmeceuticals
Fifty Years of Minocycline and Its Evolution: A Dermatological Perspective
MINOCYCLINE2021 is the 50th anniversary of the FDA approval of minocycline (MCN). While many other antibiotics have become obsolete during this time, MCN continues to be quite useful. In dermatology, MCN is used prominently in acne vulgaris, and is also employed in many other dermatological conditions because of its molecular and pharmacological properties. In this article, we review the history of minocycli …
MINOCYCLINE
PAH Post-Cryolipolysis | The Expert Weighs In
PAHSELF magazine recently covered supermodel Linda Evangelista’s recent admission that she developed paradoxical adipose hyperplasia (PAH) after undergoing cryolipolysis. The article mentions a 2017 Journal of Drugs in Dermatology review that found the incidence of PAH post-cryolipolysis may be higher than previously reported. I reached out to one of the authors of the review, Jared Jagdeo, MD, …
PAH
error

Enjoy this blog? Please spread the word :)